Feb 4, 2023 Fortune Cancer vaccines are already a reality—but your doctor might not tell you about them unless you ask Jan 19, 2023 CNBC Illumina CEO: Genomics in children’s hospitals will be the biggest part of the market Jan 12, 2023 Bio-ITWorld At J.P. Morgan Illumina Reports Rec...
that shall soon improve the landscape of personalized treatment options in NET patients. Keywords: neuroendocrine tumors; targeted therapy; personalized treatment; novel agents1. Introduction Neuroendocrine neoplasms (NENs) are a heterogeneous family of tumors that originate from the diffuse neuroendocrine ...
using mean Hamilton Rating Scale for Depression (HAM-D) score reduction as the primary outcome. In each randomized controlled trial, the drug was administered as an intravenous infusion given over 60 h. Enrolled participants were followed up on days 7 and 30 to evaluate the sustained effect. ...